Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Balancing Opioid Addiction Risk with Pain Management Needs

Larry Beresford  |  Issue: February 2018  |  February 18, 2018

arloo / SHUTTERSTOCK.COM

arloo / SHUTTERSTOCK.COM

SAN DIEGO—During a session at the ACR/ARHP 2017 Annual Meeting Nov. 3–8, three representatives from the federal government described several of the government’s varied national strategies and agencies that are tackling pain. All of these strategies are affected by the current national epidemic of opioid overdoses and the need for safer analgesic prescribing. But the government representatives also addressed the need for balancing the risks of analgesic prescribing with patients’ need to have their physicians manage their pain.

Asked whether the government viewed the issue primarily as an opioid problem or a pain problem, Linda Porter, PhD, director of the Office of Pain Policy in the National Institute of Neurological Disorders and Stroke in Bethesda, Md., responded, “We’ve tried to highlight this as a dual problem. You should see that pain management and treatment clearly are part of the government’s plan for the opioid crisis,” she said, although the epidemic of opioid overdose deaths must be urgently addressed.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“We recognize the cost of pain at the individual level and the societal level,” Dr. Porter said. “We have an opioid problem, and we have a pain problem, and we believe there’s a need to develop new pain therapies.” There are also pain modalities that could help but aren’t in use or covered, and we need more professional education to help medical trainees better understand chronic pain as well.

Dr. Porter cited the Institute of Medicine’s 2011 report, Relieving Pain in America, which first called for a coordinated, comprehensive national effort of public and private organizations to transform our understanding and treatment of pain. Data from the 2012 National Health Interview Survey (NHIS) show an estimated 25.3 million adults suffered pain every day for the preceding three months, and nearly 14 million adults experienced severe pain levels.1,2

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The Office of the Assistant Secretary for Health at the Department of Health and Human Services (DHHS) helped drive the current National Pain Strategy, released March 18, 2016. “The National Pain Strategy is the government’s first broad-ranging effort to improve how pain is perceived, assessed and treated. It’s a significant step toward the ideal state of pain care,” said Vanila M. Singh, MD, MACM, chief medical officer in the Office of the Assistant Secretary in the DHHS in Washington, D.C. The National Pain Strategy is a coordinated plan for reducing the burden of chronic pain, which affects millions of Americans at significant economic cost.

Page: 1 2 3 | Single Page
Share: 

Filed under:AnalgesicsDrug UpdatesEthicsLegal UpdatesMeeting Reports Tagged with:ACR/ARHP Annual Meetingopioid epidemicPain Management

Related Articles
    ah_designs / shutterstock.com

    The Perils of Pain Meds Revisited

    December 18, 2018

    More than 10 years ago, I wrote a commentary in The Rheumatologist, called “Perils of Pain Meds,” about the over-prescribing of opioid analgesics for common causes of chronic noncancer pain, which was a major contributor to the opioid epidemic.1 Since that time, although there has been a greater than 20% decrease in opioid prescribing, the…

    Speak Out Rheum: How Did We Go So Wrong with Opioid Prescribing?

    November 4, 2022

    I have been listening to The Fighter Pilot Podcast because my fantasy career would have been to fly a jet fighter plane (not even remotely possible, given my constitution). I learned that when an aircraft accident occurs, a mishap board is convened, not to assign blame but to try to learn what went wrong and…

    Lost and found

    The History of ACE Inhibitors in Scleroderma Renal Crisis

    February 16, 2021

    Scleroderma renal crisis is a true medical emergency in rheumatology, one that requires prompt diagnosis and treatment. Here, we review the historic introduction of the angiotensin-converting enzyme inhibitors in this context, and highlight management and key questions moving forward. Background Awareness of renal disease in scleroderma dates back many years. The revered physician William Osler…

    Rheumatologists Respond to Prescription Opioid Analgesic Crisis

    May 16, 2017

    The alarming statistics on prescription opioid overdoses are well known to medical professionals, thanks to the Centers for Disease Control and Prevention (CDC)’s widely cited finding that deaths from opioid analgesics have increased fourfold since 1999.1 Half of all fatal drug overdoses now involve opioids prescribed by a doctor. Meanwhile, a lack of rigorous research…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences